Items where authors include "Rawstron, A.C."

Article

de Tute, R.M., Cook, G. orcid.org/0000-0003-1717-0412, Cairns, D.A. orcid.org/0000-0002-2338-0179 et al. (12 more authors) (2024) Impact of minimal residual disease (MRD) in salvage autologous stem cell transplantation for relapsed myeloma: results from the NCRI Myeloma X (intensive) trial. Bone Marrow Transplantation, 59 (3). pp. 431-434. ISSN 0268-3369

de Tute, R.M., Cook, G. orcid.org/0000-0001-7196-7364, Cairns, D.A. orcid.org/0000-0002-2338-0179 et al. (12 more authors) (2024) Impact of minimal residual disease (MRD) in salvage autologous stem cell transplantation for relapsed myeloma: results from the NCRI Myeloma X (intensive) trial. Bone Marrow Transplantation, 59. pp. 431-434. ISSN 0268-3369

Alaggio, R. orcid.org/0000-0003-3915-3816, Amador, C. orcid.org/0000-0003-0352-5526, Anagnostopoulos, I. orcid.org/0000-0002-5043-6043 et al. (307 more authors) (2023) Correction: “The 5th edition of The World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms” Leukemia. 2022 Jul;36(7):1720–1748. Leukemia, 37 (9). pp. 1944-1951. ISSN 0887-6924

Rawstron, A.C., Kennedy, B., Moreton, P. et al. (5 more authors) (2004) Early prediction of outcome and response to alemtuzumab therapy in chronic lymphocytic leukemia. Blood, 103 (6). pp. 2027-2031. ISSN 0006-4971